Journal articleCell Rep Med2023
A blood-based metabolomic signature predictive of risk for pancreatic cancer.
- Journal
- Cell Rep Med
- Published
- 1 September 2023
- Citations
- 40
- Type
- Article
- License
- cc by-nc-nd
These are bibliographic fields. A study card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try
Grants 5
- Project 3 - Improving Therapy for DNA-Damage Deficient Pancreatic Adenocarcinoma P50CA127003↗
- Administrative Core P50CA221707↗
- Imaging and Molecular Correlates of Progression in Cystic Neoplasms of the Pancreas U01CA196403↗
- Clinical Validation Center for Early Detection of Pancreatic Cancer U01CA200468↗
- Altered metabolism and machine learning for pancreatic cancer early detection U01CA210171↗